Ultrasound Contrast Agents and Delivery Systems in Cancer Detection and Therapy

被引:73
|
作者
de Leon, Al [1 ]
Perera, Reshani [1 ]
Nittayacharn, Pinunta [2 ]
Cooley, Michaela [1 ]
Jung, Olive [1 ,3 ]
Exner, Agata A. [1 ,2 ]
机构
[1] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA
[3] Univ Oxford, Nuffield Dept Med, Oxford, England
来源
CANCER NANOTECHNOLOGY-BOOK | 2018年 / 139卷
关键词
MEDIATED DRUG-DELIVERY; BLOCK-COPOLYMER; MICROBUBBLES; RELEASE; DOXORUBICIN; ECHOCARDIOGRAPHY; NANOPARTICLES; CAVITATION; PRINCIPLES; LIPOSOMES;
D O I
10.1016/bs.acr.2018.04.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ultrasound is the second most utilized imaging modality in the world because it is widely accessible, robust, and safe. Aside from its extensive use in diagnostic imaging, ultrasound has also been frequently utilized in therapeutic applications. Particularly, when combined with appropriate delivery systems, ultrasound provides a flexible platform for simultaneous real-time imaging and triggered release, enabling precise, on-demand drug delivery to target sites. This chapter will discuss the basics of ultrasound including its mechanism of action and how it can be used to trigger the release of encapsulated drug either through thermal or cavitation effects. Fundamentals of ultrasound contrast agents, how they enhance ultrasound signals, and how they can be modified to function as carriers for triggered and targeted release of drugs will also be discussed.
引用
收藏
页码:57 / 84
页数:28
相关论文
共 50 条
  • [1] Induction of Apoptosis by Targeted Ultrasound Contrast Agents in Cancer Therapy
    Jablonowski, Lauren J.
    Palovcak, Averie M.
    Wheatley, Margaret A.
    2013 39TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC 2013), 2013, : 3 - 4
  • [2] Gene delivery using ultrasound contrast agents
    Unger, EC
    Hersh, E
    Vannan, M
    McCreery, T
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2001, 18 (04): : 355 - 361
  • [3] Detection modes of ultrasound contrast agents
    Meuwly, JY
    Correas, JM
    Bleuzen, A
    Tranquart, F
    JOURNAL DE RADIOLOGIE, 2003, 84 (12): : 2013 - 2024
  • [4] Detection procedures of ultrasound contrast agents
    de Jong, N
    Frinking, PJA
    Bouakaz, A
    Ten Cate, FJ
    ULTRASONICS, 2000, 38 (1-8) : 87 - 92
  • [5] Intrinsically absorbing photoacoustic and ultrasound contrast agents for cancer therapy and imaging
    Fernandes, Donald A.
    Kolios, Michael C.
    NANOTECHNOLOGY, 2018, 29 (50)
  • [6] Nano-sized Ultrasound Contrast Agents for Cancer Therapy and Theranostics
    Li, Hao
    Gan, Shenglong
    Feng, Shi-Ting
    Zhou, Guofu
    Dong, Zhi
    Zheng, Rongqin
    Li, Zi-Ping
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (35) : 5403 - 5412
  • [7] Ultrasound contrast agents and prostate cancer
    Frauscher, F
    Pallwein, L
    Klauser, A
    Berger, AP
    Koppelstaetter, F
    Gradl, J
    Schurich, M
    Bektic, J
    Pinggera, GM
    Halpern, EJ
    Horninger, W
    Bartsch, G
    Zur Nedden, D
    RADIOLOGE, 2005, 45 (06): : 544 - 551
  • [8] Liposomes as ultrasound imaging contrast agents and as ultrasound-sensitive drug delivery agents
    Huang, SL
    Hamilton, AJ
    Tiukinhoy, SD
    Nagaraj, A
    Kane, BJ
    Klegerman, M
    McPherson, DD
    MacDonald, RC
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2002, 7 (02) : 233 - 235
  • [9] Optical contrast agents and imaging systems for detection and diagnosis of cancer
    Pierce, Mark C.
    Javier, David J.
    Richards-Kortum, Rebecca
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (09) : 1979 - 1990
  • [10] Ultrasound contrast agents used for localized drug delivery
    May, D
    Dayton, P
    Chomas, J
    Allen, J
    Ferrara, K
    2000 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND 2, 2000, : 1429 - 1432